Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LEGN
LEGN logo

LEGN News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LEGN News

Legend Biotech's LB2501 Shows Promising Data for Lymphoma Treatment

2d agoNASDAQ.COM

Bluejay Diagnostics Partners with Argonaut, Shares Surge 100%

2d agoNASDAQ.COM

Promising Phase 1 Data for LB2501 CAR-T Therapy

3d agoNewsfilter

Legend Biotech Announces Phase 1 Results for LB2102 in Lung Cancer

3d agoNASDAQ.COM

LB2102 Shows Promising Clinical Activity in Small Cell Lung Cancer Trials

4d agoNewsfilter

Legend Biotech Presents Preliminary Data for LB2102 at ASCO Meeting

May 21 2026Newsfilter

First Beijing Investment Acquires Stake in Legend Biotech

May 17 2026Fool

First Beijing Investment Acquires Stake in Legend Biotech

May 17 2026Yahoo Finance

LEGN Events

06/02 16:30
US Stocks Surge to New Highs on AI Economic Strength
Stocks swung higher to new records on Tuesday as more strength from the AI economy offset the ongoing impasse between the U.S. and Iran. Chip producers and companies in the AI infrastructure space extended the momentum that has carried equity indices this year, including Broadcom, which advanced ahead of the company's earnings report due tomorrow.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Alphabetis looking to raise, including an investment from Berkshire Hathaway, to fund expansion of its AI infrastructureHP Enterpriseshares surged after the company gave an annualciting massive growth in demand for its servers and networking productsDollar Generalreportedand raised its FY26 EPS viewMarvellis set to be theNvidiaCEO Jensen Huang saidPresident Trump signed angranting the federal government oversight of AI models2. WALL STREET CALLS:Meta Platformsto Buy from Neutral at AreteWedbushTripAdvisorto Outperform on "underappreciated catalysts"Intuitto Sell at Goldman SachsNubankto Underperform at BofAPiper SandlerFulcrum to Underweight after sickle cell development stopped3. AROUND THE WEB:Tencentis close to launching an AI agent for WeChat, FT saysArmCEO Rene Haas said the U.S. will have difficulty blocking the export of CPUs to China because of their widespread use, Reuters reportsA merger between Estee Lauderand Jean Paul Gaultier-owner Puigfailed to go through due to the price tag of the transaction, but the company was still open to acquisitions if it made financial sense, Reuters saysGE Vernovawas denied its request for a court to reconsider a ruling blocking the company from ending its contract for the Vineyard Wind 1 offshore wind project, Renewables Now reportsNvidiaCEO Jensen Huang told the Computex conference in Taiwan that Anthropic, OpenAI and SpaceX are among the first big users of its upcoming microprocessor, Bloomberg says4. MOVERS:Legend Biotechrose after presentingfor LB2501 at the EHA CongressSTMicroelectronicsrises in New York after increasing its FY26 data center review guidancehttps://pro.thefly.com/STMVerra Mobilitydeclined afterCEO David Roberts will step downCelcuityfell afterfrom its PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial of gedatolisibXometryclosed lower after announcing apriced at $855. EARNINGS/GUIDANCE:Signet Jewelersreportedand narrowed its guidance for FY27Donaldsonreported, with EPS and revenue beating consensusVictoria's Secretreported, with CEO Hillary Super commenting on "a very strong start to 2026"Oddityreported, with EPS missing consensusAveannafor FY26INDEXES:The Dow rose 228.91, or 0.45%, to 51,307.79, the Nasdaq gained 7.09, or 0.026%, to 27,093.90, and the S&P 500 advanced 9.82, or 0.13%, to 7,609.78.
06/02 12:10
Alphabet Secures Funding to Expand AI Infrastructure
Stocks have edged up from record levels despite continued uncertainty regarding energy supply from the Middle East. Oil prices remain higher on the week as reports indicate strikes between Israel and Lebanon persisted despite President Trump's signal of a ceasefire.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Alphabetisin equity offerings, including an investment from Berkshire Hathaway, to fund expansion of its AI infrastructureHP Enterpriseshares have surged after the company gave anthat topped estimates, citing massive growth in demand for its servers and networking productsDollar Generalreported better-than-expectedand raised its FY26 EPS viewMarvellis set to be theNvidiaCEO Jensen Huang saidCoca-Colaexploringin India for Hindustan Coca-Cola Holdings, parent of its largest bottler in the country2. WALL STREET CALLS:Meta Platformsto Buy from Neutral at AreteWedbushTripAdvisorto Outperform on "underappreciated catalysts"Intuitto Sell at Goldman SachsNubankto Underperform at BofAPiper SandlerFulcrum to Underweight after sickle cell development stopped3. AROUND THE WEB:Tencentis close to launching an AI agent for WeChat, with the company currently testing a prototype of an agent that can help users complete tasks within the app, FT saysArmCEO Rene Haas said the U.S. will have difficulty blocking the export of CPUs to China because of their widespread use and it would be difficult to block only AI CPUs, Reuters reportsAccording to Estee Lauder CEO Stephane de La Faverie, a merger between Estee Lauderand Jean Paul Gaultier-owner Puigfailed to go through due to the price tag of the transaction, but the company was still open to acquisitions if it made financial sense, Reuters saysGE Vernovawas denied its request for a Massachusetts court to reconsider its ruling blocking the company from ending its contract for the 806-MW Vineyard Wind 1 offshore wind project, Renewables Now reportsNvidiaCEO Jensen Huang told the Computex conference in Taiwan that Anthropic, OpenAI and SpaceX are among the first big users of its upcoming microprocessor, Bloomberg says4. MOVERS:Legend Biotechhigher after presentingfor LB2501 at the EHA CongressSTMicroelectronicsrises in New York after increasing its FY26Verra Mobilitydeclines after announcing CEO Davidand Jon Keyser has been appointed interim CEOCelcuityfalls after reportingfrom its PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial of gedatolisibXometrylower after announcing apriced at $855. EARNINGS/GUIDANCE:Signet Jewelersand narrowed its guidance for FY27Donaldson, with EPS and revenue beating consensusVictoria's Secret, with CEO Hillary Super commenting on "a very strong start to 2026"Oddity, with EPS missing consensusAveannafor FY26INDEXES:Near midday, the Dow was up 0.24%, or 122.72, to 51,201.60, the Nasdaq was up 0.18%, or 49.56, to 27,136.37, and the S&P 500 was up 0.18%, or 13.91, to 7,613.87.

LEGN Monitor News

Legend Biotech Reports Promising Phase 1 Results for LB2501 CAR-T Therapy

Jun 02 2026

Legend Biotech Q1 Earnings Beat Expectations Despite Revenue Miss

May 12 2026

Legend Biotech shares surge despite market decline

Apr 20 2026

Legend Biotech reaches 20-day high amid market weakness

Feb 23 2026

Legend Biotech Downgraded Amid Market Optimism for FDA Guidance

Jan 22 2026

FDA Guidance Boosts Legend Biotech's Market Prospects

Jan 21 2026

Legend Biotech Corp Hits 52-Week Low Amid Market Weakness

Dec 09 2025

Legend Biotech Corp Hits 52-Week Low Amid Market Weakness

Dec 08 2025

LEGN Earnings Analysis

Legend Biotech Earnings: CARVYKTI® Drives Growth- Intellectia AI™
6 months ago
Legend Biotech Corporation Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch